INTERNATIONAL PATENT: SUTRO BIOPHARMA, INC. FILES APPLICATION FOR "OXOADENINE TLR7 AGONIST COMPOUNDS AND CONJUGATES"

GENEVA, Dec. 31 -- SUTRO BIOPHARMA, INC. (111 OYSTER POINT BOULEVARDSouth San Francisco, California 94080) filed a patent application (PCT/US2025/033939) for "OXOADENINE TLR7 AGONIST COMPOUNDS AND CONJUGATES" on Jun 17, 2025. With publication no. WO/2025/264647, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAHER, Samer (c/o Sutro Biopharma, Inc.111 Oyster Point BoulevardSouth San Francisco, California 94080), BAJJURI, Krishna Mohan (c/o Sutro Biopharma, Inc.111 Oyster Point BoulevardSouth San Francisco, California 9408...